NASDAQ: JSPRJasper Therapeutics Inc Earnings Dates, Reports, Calls
Jasper Therapeutics earnings were -$78.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest JSPR earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$21.2M, down 12.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, JSPR reported annual earnings of -$71.3M, with 10.6% growth.
JSPR earnings history
Current Revenue
$0.0
Current Earnings
-$78.8M
Current Profit Margin
0%
JSPR Return on Equity
Current Company
-109.5%
Current Industry
-60.2%
Current Market
31.5%
JSPR's Return on Equity (-109.5%)... subscribe to Premium to read more.
High Return on Equity Performance
JSPR undefined
Current Company
-89.8%
Current Industry
-2.5%
JSPR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when JSPR announces earnings.
JSPR undefined
Current Company
-174.05%
Current Industry
5.8%
JSPR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
JSPR vs Biotech Stocks
Jasper Therapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.